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Peritoneal Metastases Evaluation: A Comparison Between FDG-PET/CT and MRI with Correlation Between SUV and 
ADC 
Xue Yu1, Elaine Yuen Phin Lee1, and Vincent Lai1 
1Diagnostic Radiology, University of Hong Kong, Hong Kong, China 
 
Target audience Radiologists, oncologists, and other professionals working in the field of MRI and PET/CT.  
Purpose Metastatic peritoneal malignancies are associated with advanced diseases and traditionally are considered incurable. There are, 
however, new medical advances using intraperitoneal chemotherapy and hyperthermic chemotherapy, which are promising in controlling local 
disease. Moreover, cytoreductive surgery can act as a neoadjuvant treatment to chemotherapy. With these potential effective therapies, imaging 
of peritoneal metastasis becomes important for surgical planning, treatment response assessment and complications monitoring. The challenge 
remains in evaluating peritoneal dissemination due to the large anatomical coverage and no consensus exists in the use of imaging in peritoneal 
metastasis. Both FDG-PET/CT1 and MRI2 are used in the evaluation of peritoneal metastasis with gadolinium-enhanced MRI excellent in 
depicting peritoneal metastasis of small volume3. The relationship between 
glucose metabolism (measured by SUV) and tumor cellularity (quantified by 
ADC) of peritoneal metastasis derived from FDG-PET/CT and MRI respectively 
has never been evaluated. The purposes of this study are to assess the diagnostic 
performance of FDG-PET/CT, DWI, MRI and DWI/MRI in peritoneal metastasis 
evaluation; and to elucidate the correlation between SUV and ADC. 
Methods Patients with suspected peritoneal metastasis were prospectively 
recruited for FDG-PET/CT and MRI. Both examinations were performed within 4 
weeks of each other (9±8 days) without intervening therapies. Histology and 
radiological follow-ups were taken as standard of references. Sixteen anatomical 
sites in the abdomen and pelvis were systemically evaluated for peritoneal 
metastases. Images were reviewed independently by two radiologists at separate 
sessions. SUVmax, SUVmean, ADCmin and ADCmean were obtained by manually drawing ROIs over the peritoneal metastases on FDG-PET 
and DWI, respectively. Diagnostic characteristics defined by sensitivity, specificity, accuracy, positive predictive value (PPV), negative 
predictive value (NPV) and area under the curve (AUC) were calculated for DWI, MRI, DWI/MRI and FDG-PET/CT. For statistical analysis, 
McNemar test, Kappa test and Pearson’s correlation coefficient were used. Results Peritoneal metastases were confirmed in 8 patients by 
histology (50%) and radiological follow-ups (50%). A total of 128 anatomical sites were analyzed. Diagnostic performances of the different 
techniques evaluated by 2 radiologists were summarized in table 1, expressed in mean percentage. There was no statistical difference in the 
diagnostic performances of these imaging techniques in peritoneal metastases detection. Kappa values (0.901, 0.881, 0.932 and 0.977) were 
excellent for all imaging techniques. ADCmin was inversely correlated with SUVmean (r=-0.513, p=0.002, Fig.1a) and SUVmax (r=-0.508, 
p=0.002, Fig.1c). Similarly, ADCmean had negative correlation with SUVmean (r=-0.534, p=0.001, Fig.1b) and SUVmax (r=-0.518, p=0.002, 
Fig.1d). Discussions Adding DWI to conventional MRI improved the sensitivity as compared to DWI or conventional MRI (92% vs. 82% for 
DWI and 87% for MRI). DWI acquisition only added an extra 5-6 minute to the imaging time and should be performed concurrently with 
conventional MRI. DWI reveals restriction in diffusion in tumor, which provides complimentary information to conventional MRI. DWI/MRI 
and FDG-PET/CT have similar diagnostic performance but the cost of MRI is approximately half of that of FDG-PET/CT and does not involve 
radiation. Although glucose metabolism and tissue cellularity represent different facets of cell biology, our study demonstrated a relationship 
between them. Peritoneal metastasis that has high cell proliferation accompanied by increased glucose metabolism (SUV) has increased tissue 
cellularity, and therefore more restriction in diffusion, leading to lower ADC. This was consolidated by the significant negative correlation found 
between ADC and SUV. Thus both ADC and SUV could be used as measures of tumor aggressiveness and potentially parameters to monitor 
changes in the tumor microenvironment throughout therapy, preceding morphological changes. Conclusions DWI/MRI has comparable 
diagnostic performance to FDG-PET/CT in peritoneal metastases detection with DWI/MRI saving cost and negating radiation exposure. The 
significant inverse correlation between SUV and ADC suggests the relationship between glucose metabolism and tissue cellularity. ADC and 
SUV can be used synergistically or alternatively in disease detection, and potentially extending their roles in treatment response evaluation and 
disease monitoring. References [1] Kyriazi S, Kaye SB, deSouza NM. Imaging ovarian cancer and peritoneal metastases-current and emerging 
techniques. Nat Rev Clin Oncol. Jul 2010;7(7):381-393. [2] Low RN. MR imaging of the peritoneal spread of malignancy. Abdom Imaging. Jun 
2007;32(3):267-283. [3] Low RN, Sebrechts CP, Barone RM, Muller W. Diffusion-weighted MRI of peritoneal tumors: comparison with 
conventional MRI and surgical and histopathologic findings--a feasibility study. AJR Am J Roentgenol. Aug 2009;193(2):461-470. 
 
Table 1 Summary of diagnostic performance (mean value in 
percentage) 
 DWI MRI DWI/MRI PET/CT 
Sensitivity 82 87 92 90 
Specificity 99 100 99 100 
Accuracy 95 97 98 98 
PPV 96 98 97 98 
NPV 94 96 98 97 
AUC 90 93 96 95 
 
Fig.1 a-d Inverse correlation between SUVmean and ADCmin (a), SUVmean and ADCmean (b), SUVmean and ADCmin (c), SUVmax and ADCmean (d). 
1745.Proc. Intl. Soc. Mag. Reson. Med. 21 (2013) 
